Language:

Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper

The New England journal of medicine, 2023-10, Vol.389 (14), p.1263-1272 [Peer Reviewed Journal]

Full text available

Citations Cited by

Title:
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper
Author: Spiera, Robert F. ; Unizony, Sebastian ; Warrington, Kenneth J. ; Sloane, Jennifer ; Giannelou, Angeliki ; Nivens, Michael C. ; Akinlade, Bolanle ; Wong, Wanling ; Bhore, Rafia ; Lin, Yong ; Buttgereit, Frank ; Devauchelle-Pensec, Valerie ; Rubbert-Roth, Andrea ; Yancopoulos, George D. ; Marrache, Frederic ; Patel, Naimish ; Dasgupta, Bhaskar
Subjects: Allergy ; Autoimmune Disease ; Clinical Medicine ; Clinical Medicine General ; Hospital-Based Clinical Medicine ; Immunology ; Immunology General ; Inflammatory Disease ; Outpatient-Based Clinical Medicine ; Rheumatology ; Rheumatology General ; T-Cells
Is Part Of: The New England journal of medicine, 2023-10, Vol.389 (14), p.1263-1272
Description: In patients with polymyalgia rheumatica with relapse during glucocorticoid tapering, interleukin-6 receptor antagonist sarilumab increased disease remission and reduced glucocorticoid exposure at 1 year.
Publisher: Massachusetts Medical Society
Language: English
Identifier: ISSN: 0028-4793
EISSN: 1533-4406
DOI: 10.1056/NEJMoa2303452
Source: ProQuest One Psychology
AUTh Library subscriptions: ProQuest Central

Back to results list


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Searching Remote Databases, Please Wait